Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.
Identifieur interne : 000275 ( Main/Exploration ); précédent : 000274; suivant : 000276Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.
Auteurs : Jean B. Nachega [Suisse] ; Olalekan A. Uthman ; Lynne M. Mofenson ; Jean R. Anderson ; Steve Kanters ; Francoise Renaud ; Nathan Ford ; Shaffiq Essajee ; Meg C. Doherty ; Edward J. MillsSource :
- Journal of acquired immune deficiency syndromes (1999) [ 1944-7884 ] ; 2017.
Descripteurs français
- KwdFr :
- Agents antiVIH (usage thérapeutique), Complications de la grossesse et maladies infectieuses (traitement médicamenteux), Femelle, Grossesse, Humains, Infections à VIH (traitement médicamenteux), Infections à VIH (transmission), Issue de la grossesse, Nourrisson à faible poids de naissance, Nouveau-né, Numération des lymphocytes CD4, Poids de naissance (), Sécurité des patients, Transmission verticale de maladie infectieuse (), Ténofovir (effets indésirables), Ténofovir (usage thérapeutique).
- MESH :
- effets indésirables : Ténofovir.
- traitement médicamenteux : Complications de la grossesse et maladies infectieuses, Infections à VIH.
- usage thérapeutique : Agents antiVIH, Infections à VIH, Ténofovir.
- Femelle, Grossesse, Humains, Issue de la grossesse, Nourrisson à faible poids de naissance, Nouveau-né, Numération des lymphocytes CD4, Poids de naissance, Sécurité des patients, Transmission verticale de maladie infectieuse.
English descriptors
- KwdEn :
- Anti-HIV Agents (therapeutic use), Birth Weight (drug effects), CD4 Lymphocyte Count, Female, HIV Infections (drug therapy), HIV Infections (transmission), Humans, Infant, Low Birth Weight, Infant, Newborn, Infectious Disease Transmission, Vertical (prevention & control), Patient Safety, Pregnancy, Pregnancy Complications, Infectious (drug therapy), Pregnancy Outcome, Tenofovir (adverse effects), Tenofovir (therapeutic use).
- MESH :
- chemical , adverse effects : Tenofovir.
- chemical , therapeutic use : Anti-HIV Agents, Tenofovir.
- drug effects : Birth Weight.
- drug therapy : HIV Infections, Pregnancy Complications, Infectious.
- prevention & control : Infectious Disease Transmission, Vertical.
- transmission : HIV Infections.
- CD4 Lymphocyte Count, Female, Humans, Infant, Low Birth Weight, Infant, Newborn, Patient Safety, Pregnancy, Pregnancy Outcome.
Abstract
There are limited data on adverse effects of tenofovir disoproxil fumarate (TDF)-based antiretroviral therapy (ART) on pregnant women and their infants.
DOI: 10.1097/QAI.0000000000001359
PubMed: 28291053
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000D75
- to stream PubMed, to step Curation: 000D75
- to stream PubMed, to step Checkpoint: 000D75
- to stream Ncbi, to step Merge: 003F02
- to stream Ncbi, to step Curation: 003F02
- to stream Ncbi, to step Checkpoint: 003F02
- to stream Main, to step Merge: 000275
- to stream Main, to step Curation: 000275
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.</title><author><name sortKey="Nachega, Jean B" sort="Nachega, Jean B" uniqKey="Nachega J" first="Jean B" last="Nachega">Jean B. Nachega</name><affiliation wicri:level="4"><nlm:affiliation>*Departments of Epidemiology, Microbiology and Infectious Diseases, University of Pittsburgh, Pittsburgh, PA; †Department of Medicine, Centre for Infectious Diseases, Stellenbosch University, Cape Town, South Africa; ‡Departments of Epidemiology and International Health, Johns Hopkins University, Baltimore, MD; §Centre for Applied Health Research & Delivery, Warwick Medical School, The University of Warwick, Coventry, United Kingdom; ‖Department of Public Health (IHCAR), Karolinska Institute, Stockholm, Sweden; ¶Department of Global Health, Centre for Evidence-Based Health Care, Stellenbosch University, Tygerberg, South Africa; #Elizabeth Glazer Pediatric AIDS Foundation, Washington, DC; **Department of Obstetrics and Gynecology, Johns Hopkins School of Medicine, Baltimore, MD; ††Department of Statistics, University of British Columbia, Vancouver, Canada; ‡‡Global Evaluative Science, Vancouver, Canada; and §§Department of HIV, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>*Departments of Epidemiology, Microbiology and Infectious Diseases, University of Pittsburgh, Pittsburgh, PA; †Department of Medicine, Centre for Infectious Diseases, Stellenbosch University, Cape Town, South Africa; ‡Departments of Epidemiology and International Health, Johns Hopkins University, Baltimore, MD; §Centre for Applied Health Research & Delivery, Warwick Medical School, The University of Warwick, Coventry, United Kingdom; ‖Department of Public Health (IHCAR), Karolinska Institute, Stockholm, Sweden; ¶Department of Global Health, Centre for Evidence-Based Health Care, Stellenbosch University, Tygerberg, South Africa; #Elizabeth Glazer Pediatric AIDS Foundation, Washington, DC; **Department of Obstetrics and Gynecology, Johns Hopkins School of Medicine, Baltimore, MD; ††Department of Statistics, University of British Columbia, Vancouver, Canada; ‡‡Global Evaluative Science, Vancouver, Canada; and §§Department of HIV, World Health Organization, Geneva</wicri:regionArea><orgName type="university">Université de Pittsburgh</orgName><placeName><settlement type="city">Pittsburgh</settlement><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Uthman, Olalekan A" sort="Uthman, Olalekan A" uniqKey="Uthman O" first="Olalekan A" last="Uthman">Olalekan A. Uthman</name></author><author><name sortKey="Mofenson, Lynne M" sort="Mofenson, Lynne M" uniqKey="Mofenson L" first="Lynne M" last="Mofenson">Lynne M. Mofenson</name></author><author><name sortKey="Anderson, Jean R" sort="Anderson, Jean R" uniqKey="Anderson J" first="Jean R" last="Anderson">Jean R. Anderson</name></author><author><name sortKey="Kanters, Steve" sort="Kanters, Steve" uniqKey="Kanters S" first="Steve" last="Kanters">Steve Kanters</name></author><author><name sortKey="Renaud, Francoise" sort="Renaud, Francoise" uniqKey="Renaud F" first="Francoise" last="Renaud">Francoise Renaud</name></author><author><name sortKey="Ford, Nathan" sort="Ford, Nathan" uniqKey="Ford N" first="Nathan" last="Ford">Nathan Ford</name></author><author><name sortKey="Essajee, Shaffiq" sort="Essajee, Shaffiq" uniqKey="Essajee S" first="Shaffiq" last="Essajee">Shaffiq Essajee</name></author><author><name sortKey="Doherty, Meg C" sort="Doherty, Meg C" uniqKey="Doherty M" first="Meg C" last="Doherty">Meg C. Doherty</name></author><author><name sortKey="Mills, Edward J" sort="Mills, Edward J" uniqKey="Mills E" first="Edward J" last="Mills">Edward J. Mills</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28291053</idno><idno type="pmid">28291053</idno><idno type="doi">10.1097/QAI.0000000000001359</idno><idno type="wicri:Area/PubMed/Corpus">000D75</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D75</idno><idno type="wicri:Area/PubMed/Curation">000D75</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D75</idno><idno type="wicri:Area/PubMed/Checkpoint">000D75</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000D75</idno><idno type="wicri:Area/Ncbi/Merge">003F02</idno><idno type="wicri:Area/Ncbi/Curation">003F02</idno><idno type="wicri:Area/Ncbi/Checkpoint">003F02</idno><idno type="wicri:Area/Main/Merge">000275</idno><idno type="wicri:Area/Main/Curation">000275</idno><idno type="wicri:Area/Main/Exploration">000275</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.</title><author><name sortKey="Nachega, Jean B" sort="Nachega, Jean B" uniqKey="Nachega J" first="Jean B" last="Nachega">Jean B. Nachega</name><affiliation wicri:level="4"><nlm:affiliation>*Departments of Epidemiology, Microbiology and Infectious Diseases, University of Pittsburgh, Pittsburgh, PA; †Department of Medicine, Centre for Infectious Diseases, Stellenbosch University, Cape Town, South Africa; ‡Departments of Epidemiology and International Health, Johns Hopkins University, Baltimore, MD; §Centre for Applied Health Research & Delivery, Warwick Medical School, The University of Warwick, Coventry, United Kingdom; ‖Department of Public Health (IHCAR), Karolinska Institute, Stockholm, Sweden; ¶Department of Global Health, Centre for Evidence-Based Health Care, Stellenbosch University, Tygerberg, South Africa; #Elizabeth Glazer Pediatric AIDS Foundation, Washington, DC; **Department of Obstetrics and Gynecology, Johns Hopkins School of Medicine, Baltimore, MD; ††Department of Statistics, University of British Columbia, Vancouver, Canada; ‡‡Global Evaluative Science, Vancouver, Canada; and §§Department of HIV, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>*Departments of Epidemiology, Microbiology and Infectious Diseases, University of Pittsburgh, Pittsburgh, PA; †Department of Medicine, Centre for Infectious Diseases, Stellenbosch University, Cape Town, South Africa; ‡Departments of Epidemiology and International Health, Johns Hopkins University, Baltimore, MD; §Centre for Applied Health Research & Delivery, Warwick Medical School, The University of Warwick, Coventry, United Kingdom; ‖Department of Public Health (IHCAR), Karolinska Institute, Stockholm, Sweden; ¶Department of Global Health, Centre for Evidence-Based Health Care, Stellenbosch University, Tygerberg, South Africa; #Elizabeth Glazer Pediatric AIDS Foundation, Washington, DC; **Department of Obstetrics and Gynecology, Johns Hopkins School of Medicine, Baltimore, MD; ††Department of Statistics, University of British Columbia, Vancouver, Canada; ‡‡Global Evaluative Science, Vancouver, Canada; and §§Department of HIV, World Health Organization, Geneva</wicri:regionArea><orgName type="university">Université de Pittsburgh</orgName><placeName><settlement type="city">Pittsburgh</settlement><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Uthman, Olalekan A" sort="Uthman, Olalekan A" uniqKey="Uthman O" first="Olalekan A" last="Uthman">Olalekan A. Uthman</name></author><author><name sortKey="Mofenson, Lynne M" sort="Mofenson, Lynne M" uniqKey="Mofenson L" first="Lynne M" last="Mofenson">Lynne M. Mofenson</name></author><author><name sortKey="Anderson, Jean R" sort="Anderson, Jean R" uniqKey="Anderson J" first="Jean R" last="Anderson">Jean R. Anderson</name></author><author><name sortKey="Kanters, Steve" sort="Kanters, Steve" uniqKey="Kanters S" first="Steve" last="Kanters">Steve Kanters</name></author><author><name sortKey="Renaud, Francoise" sort="Renaud, Francoise" uniqKey="Renaud F" first="Francoise" last="Renaud">Francoise Renaud</name></author><author><name sortKey="Ford, Nathan" sort="Ford, Nathan" uniqKey="Ford N" first="Nathan" last="Ford">Nathan Ford</name></author><author><name sortKey="Essajee, Shaffiq" sort="Essajee, Shaffiq" uniqKey="Essajee S" first="Shaffiq" last="Essajee">Shaffiq Essajee</name></author><author><name sortKey="Doherty, Meg C" sort="Doherty, Meg C" uniqKey="Doherty M" first="Meg C" last="Doherty">Meg C. Doherty</name></author><author><name sortKey="Mills, Edward J" sort="Mills, Edward J" uniqKey="Mills E" first="Edward J" last="Mills">Edward J. Mills</name></author></analytic><series><title level="j">Journal of acquired immune deficiency syndromes (1999)</title><idno type="eISSN">1944-7884</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-HIV Agents (therapeutic use)</term><term>Birth Weight (drug effects)</term><term>CD4 Lymphocyte Count</term><term>Female</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (transmission)</term><term>Humans</term><term>Infant, Low Birth Weight</term><term>Infant, Newborn</term><term>Infectious Disease Transmission, Vertical (prevention & control)</term><term>Patient Safety</term><term>Pregnancy</term><term>Pregnancy Complications, Infectious (drug therapy)</term><term>Pregnancy Outcome</term><term>Tenofovir (adverse effects)</term><term>Tenofovir (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Agents antiVIH (usage thérapeutique)</term><term>Complications de la grossesse et maladies infectieuses (traitement médicamenteux)</term><term>Femelle</term><term>Grossesse</term><term>Humains</term><term>Infections à VIH (traitement médicamenteux)</term><term>Infections à VIH (transmission)</term><term>Issue de la grossesse</term><term>Nourrisson à faible poids de naissance</term><term>Nouveau-né</term><term>Numération des lymphocytes CD4</term><term>Poids de naissance ()</term><term>Sécurité des patients</term><term>Transmission verticale de maladie infectieuse ()</term><term>Ténofovir (effets indésirables)</term><term>Ténofovir (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Tenofovir</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-HIV Agents</term><term>Tenofovir</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Birth Weight</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Ténofovir</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Infectious Disease Transmission, Vertical</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Complications de la grossesse et maladies infectieuses</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agents antiVIH</term><term>Infections à VIH</term><term>Ténofovir</term></keywords><keywords scheme="MESH" xml:lang="en"><term>CD4 Lymphocyte Count</term><term>Female</term><term>Humans</term><term>Infant, Low Birth Weight</term><term>Infant, Newborn</term><term>Patient Safety</term><term>Pregnancy</term><term>Pregnancy Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Femelle</term><term>Grossesse</term><term>Humains</term><term>Issue de la grossesse</term><term>Nourrisson à faible poids de naissance</term><term>Nouveau-né</term><term>Numération des lymphocytes CD4</term><term>Poids de naissance</term><term>Sécurité des patients</term><term>Transmission verticale de maladie infectieuse</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">There are limited data on adverse effects of tenofovir disoproxil fumarate (TDF)-based antiretroviral therapy (ART) on pregnant women and their infants.</div></front></TEI><affiliations><list><country><li>Suisse</li></country><region><li>Pennsylvanie</li></region><settlement><li>Pittsburgh</li></settlement><orgName><li>Université de Pittsburgh</li></orgName></list><tree><noCountry><name sortKey="Anderson, Jean R" sort="Anderson, Jean R" uniqKey="Anderson J" first="Jean R" last="Anderson">Jean R. Anderson</name><name sortKey="Doherty, Meg C" sort="Doherty, Meg C" uniqKey="Doherty M" first="Meg C" last="Doherty">Meg C. Doherty</name><name sortKey="Essajee, Shaffiq" sort="Essajee, Shaffiq" uniqKey="Essajee S" first="Shaffiq" last="Essajee">Shaffiq Essajee</name><name sortKey="Ford, Nathan" sort="Ford, Nathan" uniqKey="Ford N" first="Nathan" last="Ford">Nathan Ford</name><name sortKey="Kanters, Steve" sort="Kanters, Steve" uniqKey="Kanters S" first="Steve" last="Kanters">Steve Kanters</name><name sortKey="Mills, Edward J" sort="Mills, Edward J" uniqKey="Mills E" first="Edward J" last="Mills">Edward J. Mills</name><name sortKey="Mofenson, Lynne M" sort="Mofenson, Lynne M" uniqKey="Mofenson L" first="Lynne M" last="Mofenson">Lynne M. Mofenson</name><name sortKey="Renaud, Francoise" sort="Renaud, Francoise" uniqKey="Renaud F" first="Francoise" last="Renaud">Francoise Renaud</name><name sortKey="Uthman, Olalekan A" sort="Uthman, Olalekan A" uniqKey="Uthman O" first="Olalekan A" last="Uthman">Olalekan A. Uthman</name></noCountry><country name="Suisse"><region name="Pennsylvanie"><name sortKey="Nachega, Jean B" sort="Nachega, Jean B" uniqKey="Nachega J" first="Jean B" last="Nachega">Jean B. Nachega</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000275 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000275 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28291053
|texte= Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28291053" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |